
Agena Bioscience Launches High-Throughput, Low-Cost SARS-CoV-2 Detection Panel in Europe with CE-IVD Marking
Agena Bioscience, a global provider of low cost and high-throughput molecular testing solutions, today announced that it…
Agena Bioscience, a global provider of low cost and high-throughput molecular testing solutions, today announced that it…
Mit der Einführung des MassARRAY® Compact Analyzers* der Firma Sequenom erweitert die ATLAS Biolabs GmbH ihr Serviceange…
QIAGEN GmbH, eine hundertprozentige Tochtergesellschaft der QIAGEN N.V. (Nasdaq: QGEN, Frankfurt, Prime Standard: QIA) u…
QIAGEN GmbH, a wholly-owned subsidiary of QIAGEN N.V. (Nasdaq: QGEN, Frankfurt, Prime Standard: QIA) and Sequenom, Inc.…